CSAM Health Group AS
CSAMF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $121,182 | $115,358 | $9,526 | $104,166 |
| % Growth | 5% | 1,110.9% | -90.9% | – |
| Cost of Goods Sold | $7,658 | $9,057 | $6,745 | $7,696 |
| Gross Profit | $113,524 | $106,301 | $2,781 | $96,470 |
| % Margin | 93.7% | 92.1% | 29.2% | 92.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | -$542 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $102,555 | $113,742 | $0 | $96,470 |
| Operating Expenses | $102,555 | $113,742 | -$542 | $96,470 |
| Operating Income | $10,969 | -$7,441 | $3,323 | -$3,990 |
| % Margin | 9.1% | -6.5% | 34.9% | -3.8% |
| Other Income/Exp. Net | -$3,998 | -$21,879 | -$2,550 | -$21,415 |
| Pre-Tax Income | $6,971 | -$29,320 | $774 | -$25,405 |
| Tax Expense | -$875 | $2,946 | -$158 | -$1,786 |
| Net Income | $7,846 | -$32,266 | $932 | -$23,620 |
| % Margin | 6.5% | -28% | 9.8% | -22.7% |
| EPS | 0.39 | -1.6 | 0.046 | -1.16 |
| % Growth | 124.4% | -3,563.2% | 104% | – |
| EPS Diluted | 0.39 | -1.6 | 0.046 | -1.16 |
| Weighted Avg Shares Out | 20,180 | 20,180 | 20,180 | 20,308 |
| Weighted Avg Shares Out Dil | 20,180 | 20,180 | 20,180 | 20,308 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,763 | -$6,976 | $15,958 | -$6,271 |
| Interest Expense | $14,762 | $14,903 | $15,284 | $15,145 |
| Depreciation & Amortization | $15,574 | $12,879 | $1,398 | $14,426 |
| EBITDA | $37,307 | -$1,538 | $2,090 | $4,166 |
| % Margin | 30.8% | -1.3% | 21.9% | 4% |